{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:22:26Z","timestamp":1790392946476,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012497","name":"Covenant University Centre for Research, Innovation and Discovery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.critrevonc.2026.105251","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:01:19Z","timestamp":1772848879000},"page":"105251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Disparities in diagnosis, treatment, and outcomes of early-onset breast cancer: A global perspective"],"prefix":"10.1016","volume":"221","author":[{"given":"Shalom Nwodo","family":"Chinedu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9690-6373","authenticated-orcid":false,"given":"Peace Nzubechukwu","family":"Ogbodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalene Eno","family":"Effiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.critrevonc.2026.105251_bib1","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/S1470-2045(12)70598-3","article-title":"Improvement of pathology in sub-Saharan Africa","volume":"14","author":"Adesina","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105251_bib2","unstructured":"Africa CDC (2026) African Pooled Procurement Mechanism (APPM) \u2013 Africa CDC. 2026. \u3008https:\/\/africacdc.org\/appm\/\u3009 [Accessed: 12 February 2026]."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-022-02142-w","article-title":"Clinicopathologic characteristics of early-onset breast cancer: a comparative analysis of cases from across Ghana","volume":"23","author":"Akakpo","year":"2023","journal-title":"BMC Women\u2019S. Health"},{"key":"10.1016\/j.critrevonc.2026.105251_bib4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3332\/ecancer.2021.1192","article-title":"Pattern of survival of breast cancer patients in a tertiary hospital in South West Nigeria","volume":"15","author":"Ali-Gombe","year":"2021","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.critrevonc.2026.105251_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.797505","article-title":"The mutational landscape of early-onset breast cancer: a next-generation sequencing analysis","volume":"11","author":"Andrikopoulou","year":"2022","journal-title":"Front. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105251_bib6","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S1470-2045(15)00135-7","article-title":"Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial","volume":"16","author":"Badwe","year":"2015","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105251_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(18)30257-2","article-title":"Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study","volume":"6","author":"Birnbaum","year":"2018","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12992-018-0446-6","article-title":"Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward","volume":"15","author":"Black","year":"2019","journal-title":"Glob. Health"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105251_bib9","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.1634\/theoncologist.2019-0057","article-title":"Delays and barriers to cancer care in low- and middle-income countries: a systematic review","volume":"24","author":"Brand","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2026.105251_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12688\/gatesopenres.13110.3","article-title":"Value-based tiered pricing for universal health coverage: an idea worth revisiting","volume":"4","author":"Chalkidou","year":"2020","journal-title":"Gates Open Res. 2020"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4956-7","article-title":"Overall survival and time trends in breast and cervical cancer incidence and mortality in the Regional Health District (RHD) of Barretos, S\u00e3o Paulo, Brazil","volume":"18","author":"Da Costa","year":"2018","journal-title":"BMC Cancer"},{"issue":"10071","key":"10.1016\/j.critrevonc.2026.105251_bib12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(16)31795-0","article-title":"Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries","volume":"389","author":"Denny","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5639\/gabij.2018.0701.007","article-title":"Patent expiry dates for biologicals: 2017 update","volume":"7","author":"Derbyshire","year":"2018","journal-title":"GaBI J."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105251_bib14","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1055-9965.EPI-15-0535","article-title":"International variation in female breast cancer incidence and mortality rates","volume":"24","author":"DeSantis","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.amepre.2013.08.016","article-title":"Health and economic impact of breast cancer mortality in young women, 1970\u20132008","volume":"46","author":"Ekwueme","year":"2014","journal-title":"Am. J. Prev. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105251_bib16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cncr.21285","article-title":"The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999","volume":"104","author":"Elkin","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105251_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-023-02803-4","article-title":"Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases","volume":"23","author":"Fernandes","year":"2023","journal-title":"BMC Women\u2019S. Health"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105251_bib19","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1245\/s10434-023-14080-4","article-title":"Genomic characterization of aggressive breast cancer in younger women","volume":"30","author":"Franco","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105251_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103835","article-title":"Current and future burden of breast cancer in Asia: a GLOBOCAN data analysis for 2022 and 2050","volume":"79","author":"Fu","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2026.105251_bib21","unstructured":"GLOBOCAN (2022) 900 World Factsheet, Cancer Today."},{"issue":"42","key":"10.1016\/j.critrevonc.2026.105251_bib22","doi-asserted-by":"crossref","first-page":"71548","DOI":"10.18632\/oncotarget.17742","article-title":"A global comparison of the cost of patented cancer drugs in relation to global differences in wealth","volume":"8","author":"Goldstein","year":"2017","journal-title":"Oncotarget"},{"issue":"52","key":"10.1016\/j.critrevonc.2026.105251_bib23","doi-asserted-by":"crossref","first-page":"89425","DOI":"10.18632\/oncotarget.21976","article-title":"Cancer drugs in LMICs: cheap but unaffordable","volume":"8","author":"Gyawali","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105251_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30751-8","article-title":"Lancet oncology commission on medical imaging and nuclear medicine","volume":"22","author":"Hricak","year":"2021","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105251_bib25","article-title":"An economic evaluation of breast cancer interventions in Kenya","volume":"77","author":"Hutchinson","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105251_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.6004\/jnccn.2018.0083","article-title":"Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Jacobs","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105251_bib27","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/ijc.32406","article-title":"Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study","volume":"146","author":"Joko-Fru","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105251_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jval.2021.08.014","article-title":"The use of cost-effectiveness thresholds for evaluating health interventions in low- and middle-income countries from 2015 to 2020: a review","volume":"25","author":"Kazibwe","year":"2022","journal-title":"Value Health"},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105251_bib29","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","article-title":"Breast-cancer screening \u2014 viewpoint of the IARC working group","volume":"372","author":"Lauby-Secretan","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105251_bib30","article-title":"Inequality in breast cancer: global statistics from 2022 to 2050","volume":"79","author":"Liao","year":"2025","journal-title":"Breast (Edinb. Scotl. )"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105251_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.10260","article-title":"Survival patterns among patients with breast cancer in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"7","author":"Limenih","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105251_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.radonc.2014.03.013","article-title":"Radiation therapy: a major factor in the five-year survival analysis of women with breast cancer in Lagos, Nigeria","volume":"111","author":"Makanjuola","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cll.2017.10.013","article-title":"Breast cancer in low- and middle-income countries: why we need pathology capability to solve this challenge","volume":"38","author":"Martei","year":"2017","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.critrevonc.2026.105251_bib34","unstructured":"Medicines Patent Pool (2023) MPP. 27 September 2023. \u3008https:\/\/medicinespatentpool.org\/uploads\/2023\/09\/MPP_Snapshots_2023_2024_RD_PDF_-Trastuzumab-SQ.pdf\u3009 [Accessed: 12 February 2026]."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105251_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/ijmr.IJMR_2635_20","article-title":"Screening for breast cancer: Cost-effective solutions for low- & middle-income countries","volume":"154","author":"Mishra","year":"2021","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2015.61.9767","article-title":"Oncologic care and pathology resources in Africa: survey and recommendations","volume":"34","author":"Nelson","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12885-024-13420-1","article-title":"Pathway to care among adolescents and young adults with breast cancer in Nigeria: a mixed methods study","volume":"25","author":"Ntekim","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105251_bib38","unstructured":"Office for National Statistics (2019) Cancer survival in England - adults diagnosed - Office for National Statistics. 12 August 2019. \u3008https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/datasets\/cancersurvivalratescancersurvivalinenglandadultsdiagnosed\u3009 [Accessed: 23 June 2025]."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105251_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s13193-018-0800-4","article-title":"Rising Incidence of Breast Cancer in the Young Fertile Indian Population\u2014a Reality Check","volume":"9","author":"Parmar","year":"2018","journal-title":"Indian J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105251_bib40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1634\/theoncologist.2011-0469","article-title":"The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer","volume":"17","author":"Partridge","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2026.105251_bib41","unstructured":"Pearce I.P. (2023) Glenmark provides 70% price drop for breast cancer drug Trumab\u00ae, biosimilar trastuzumab | Pearce IP. 15 June 2023. \u3008https:\/\/www.pearceip.law\/2023\/06\/15\/glenmark-provides-70-price-drop-for-breast-cancer-drug-trumab-biosimilar-trastuzumab\/\u3009 [Accessed: 12 February 2026]."},{"issue":"16_","key":"10.1016\/j.critrevonc.2026.105251_bib42","article-title":"Shifting trends in the usage of trastuzumab with its biosimilar inception in India","volume":"41","author":"Ramanjinappa","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105251_bib43","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1158\/1078-0432.CCR-16-2630","article-title":"Breast Cancer Disparities at home and abroad: A Review of the Challenges and Opportunities for System-Level Change","volume":"23","author":"Reeder-Hayes","year":"2017","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"key":"10.1016\/j.critrevonc.2026.105251_bib44","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol. Comm. Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105251_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/1178223417752677","article-title":"Delays in Breast Cancer Detection and Treatment in Developing Countries","volume":"12","author":"Rivera-Franco","year":"2018","journal-title":"Breast Cancer Basic Clinical Research"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105251_bib46","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.5858\/arpa.2013-0200-OA","article-title":"Pathologist Workforce in the United States: I. Development of a Predictive Model to Examine Factors Influencing Supply","volume":"137","author":"Robboy","year":"2013","journal-title":"Arch. Pathol. & Lab. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105251_bib47","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/cncr.35188","article-title":"Breast cancer survival in India across 11 geographic areas under the National Cancer Registry Programme","volume":"130","author":"Sathishkumar","year":"2024","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105251_bib48","article-title":"Training health workers in clinical breast examination for early detection of breast cancer in low- and middle-income countries","volume":"2023","author":"Sayed","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.critrevonc.2026.105251_bib49","unstructured":"SEER (2022) Female Breast Cancer - Cancer Stat Facts. 2022. \u3008https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html\u3009 [Accessed: 23 June 2025]."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-024-13381-5","article-title":"Breast cancer patterns by age groups in Brazil: insights from population-based registries data","volume":"25","author":"da Silva","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105251_bib51","first-page":"1620","article-title":"Young Women with Breast Cancer: The Current Role of Precision Oncology","volume":"13","author":"Srikanthan","year":"2023","journal-title":"J. Pers. Med. 2023"},{"key":"10.1016\/j.critrevonc.2026.105251_bib52","unstructured":"U.S. CDC (2024) U.S. Cancer Statistics Breast Cancer Stat Bite | U.S. Cancer Statistics | CDC. 13 June 2024. \u3008https:\/\/www.cdc.gov\/united-states-cancer-statistics\/publications\/breast-cancer-stat-bite.html\u3009 [Accessed: 14 May 2025]."},{"key":"10.1016\/j.critrevonc.2026.105251_bib53","article-title":"Quality of care in Colombian women with early-onset breast cancer in two time periods: findings from a nationwide administrative registry cohort","volume":"43","author":"Valbuena-Garcia","year":"2025","journal-title":"Lancet Reg. Health Am."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105251_bib54","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S1470-2045(21)00403-4","article-title":"The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis","volume":"22","author":"Ward","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105251_bib55","unstructured":"WHO (2025a) Breast cancer. 3 February 2025. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer\u3009 [Accessed: 19 May 2025]."},{"key":"10.1016\/j.critrevonc.2026.105251_bib56","unstructured":"WHO (2025b) Breast cancer inequities. 2025. \u3008https:\/\/www.who.int\/initiatives\/global-breast-cancer-initiative\/breast-cancer-inequities\u3009 [Accessed: 14 May 2025]."},{"key":"10.1016\/j.critrevonc.2026.105251_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vhri.2023.01.006","article-title":"Cost-effectiveness of breast cancer early detection program in low- and middle-income countries: a systematic review","volume":"35","author":"Yeong","year":"2023","journal-title":"Value Health Reg. Issues"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105251_bib58","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1245\/ASO.2006.03.055","article-title":"Breast cancer diagnosis in women \u2264 40 versus 50\u201360 Years: increasing size and stage disparity compared with older women over time","volume":"13","author":"Zabicki","year":"2006","journal-title":"Ann. Surg. Oncol. 2006"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105251_bib59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1365-3156.2012.03021.x","article-title":"Costs, effects and cost-effectiveness of breast cancer control in Ghana","volume":"17","author":"Zelle","year":"2012","journal-title":"Trop. Med. Int. Health"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105251_bib60","first-page":"49","article-title":"Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019","volume":"2","author":"Zhao","year":"2023","journal-title":"BMJ Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105251_bib61","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/cancers15061917","article-title":"What is known about breast cancer in young women?","volume":"15","author":"Zhu","year":"2023","journal-title":"Cancers"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:42:37Z","timestamp":1776127357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":61,"alternative-id":["S1040842826001381"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105251","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in diagnosis, treatment, and outcomes of early-onset breast cancer: A global perspective","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105251"}}